Leucadia Therapeutics Inc Company

Leucadia Therapeutics Inc is privately-held, pre-clinical stage company focused on Alzheimer's disease prevention and treatment. The company is developing a diagnostic algorithm for Alzheimer's disease risk based on big data. A therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment (MCI) from progressing to Alzheimer's disease. (alzheimers Alzheimers alzheimer's neurodegeneration)
Technology: Big Data, Biotechnology, Health Diagnostics, Life Science, Medical Device, Neuroscience
Industry: Early Drug Development, Preclinical Development
Headquarters: Riverside, California, United States
Founded Date: 2015-10-29
Employees Number: 1-10
Funding Status: Seed
Investors Number: 1
Estimated Revenue: $1M to $10M
Last Funding Date: 2019-06-25
Last Funding Type: Seed

Visit Website
info@leucadiatx.com
Register and Claim Ownership